Tim F. Greten
National Institutes of Health(US)Allegheny Health Network(US)National Cancer Institute(US)Center for Cancer Research(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Hepatocellular Carcinoma Treatment and Prognosis, Immunotherapy and Immune Responses, Pancreatic and Hepatic Oncology Research, Immune Cell Function and Interaction
Most-Cited Works
- → Sorafenib in Advanced Hepatocellular Carcinoma(2008)12,835 cited
- → Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade(2017)6,510 cited
- → Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards(2016)2,672 cited
- → IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer(2004)2,409 cited
- EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer(2012)
- → Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells(2018)1,438 cited
- → Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma